Showing results (71-80 of 342) with videos related to

Sort By:
Pageof 35
Cancers|August 14, 2025
Correction: Mancuso et al. Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma. Cancers 2025, 17, 1168Katia Mancuso, Simona Barbato, Francesco Di Raimondo, et al.
Leukemia Research|August 3, 2010
Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AMLVincenza Barresi, Giuseppe Alberto Palumbo, Nicolò Musso, et al.
Antioxidants & Redox Signaling|March 5, 2017
The Heme Oxygenase System in Hematological MalignanciesGiovanni Li Volti, Daniele Tibullo, Luca Vanella, et al.
European Journal of Haematology|March 8, 2020
The multi-tyrosine kinase inhibitor ponatinib for chronic myeloid leukemia: Real-world dataLuigia Luciano, Mario Annunziata, Immacolata Attolico, et al.
Journal of Clinical Apheresis|September 29, 2015
Erythrocytapheresis is a valid and safe therapeutic option in dysmetabolic iron overload syndromeCalogero Vetro, Rosamaria Rosso, Stefano Palmucci, et al.
Blood Reviews|April 12, 2025
Navigating acute myeloid leukemia towards better outcomes: Treatment pathways and challenges for patients ineligible for intensive chemotherapyRaffaele Palmieri, Anna Candoni, Francesco Di Raimondo, et al.
Acta Haematologica|November 28, 2021
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game OverAnnalisa Condorelli, Bruno Garibaldi, Caterina Gagliano, et al.
Journal of Clinical Medicine|December 10, 2021
Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic CellsMichele Massimino, Paolo Vigneri, Stefania Stella, et al.
International Journal of Molecular Sciences|October 14, 2022
Label-Free Enrichment of Circulating Tumor Plasma Cells: Future Potential Applications of Dielectrophoresis in Multiple MyelomaNicolò Musso, Alessandra Romano, Paolo Giuseppe Bonacci, et al.
Hematological Oncology|May 6, 2011
Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donorsDaniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, et al.
Pageof 35